Literature DB >> 1263111

Physiological disposition and biotransformation of (3H) cocaine in acutely and chronically treated rats.

P K Nayak, A L Misra, S J Mulé.   

Abstract

A sensitive method was developed for the estimation of [3H] cocaine in biological materials. After an injection of 8 mg/kg i.v. in male Wistar rats, peak levels in brain, tissues and plasma occurred within 15 minutes and cocaine disappeared completely from brain and plasma 6 hours postinjection. The T1/2 of cocaine in brain and plasma was 0.4 and 0.3 hour, respectively. No significant differences were observed in the rates of disappearance of cocaine from the subcutaneous site in acute and chronically treated rats after an injection of 20 mg/kg. After a 20 mg/kg s. c. dose, the peak levels of cocaine were attained gradually in 4 hours in brain, tissues and plasma with the exception of heart (0.5 hour) and fat (2 hours). These peak levels shifted from 4 to 2 hours in the chronically treated group. Consistently higher levels of cocaine were found to be sequestered in fat in the chronically treated animals. The T1/2 of cocaine in brain and plasma of chronically treated rats was approximately 1.8 to 2 hours and that in the acutely treated animals, 0.8 to 1 hour. The brain/plasma ratios were also somewhat higher in chronically treated as compared to the acutely treated animals and were indicative of a high affinity of tissue for cocaine. Although cocaine did not persist in brains of acutely treated animals, measurable amounts were shown to persist in brain and other tissues of chronically treated animals long after the disappearance in plasma. Significantly high concentrations of metabolites of cocaine persisted in brain and plasma of acutely and chronically treated animals. No significant differences were observed in the plasma protein binding of cocaine in control, acutely and chronically treated rats. Unchanged cocaine was excreted in very small amounts in rat bile and approximately 36% of the dose (5 mg/kg i. v.) was excreted as metabolites 3.5 hours after injection. Excretion of free cocaine in urine and feces after a 20 mg/kg s. c. dose in acutely and chronically treated rats was 1.2 and 1.5%, respectively. Significantly higher excretion of total radioactivity occurred in feces in the chronic group (35.9%) as compared to the acute group (22.1%). Benzoylecgonine, benzoyl norecgonine, ecgonine methyl ester and ecgonine were identified as urinary metabolites in both acute and chronic animals. In addition, evidence was obtained for the presence of a phenolic metabolite and two other hydroxylated metabolites (with hydroxylation presumably in positions 6 and 7 of the pyrrolidine ring). Implications of these observations with respect to systemic toxicity, the absence of tolerance and physical dependence liability of cocaine are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1263111

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  39 in total

1.  Slow phasic and tonic activity of ventral pallidal neurons during cocaine self-administration.

Authors:  David H Root; Anthony T Fabbricatore; Anthony P Pawlak; David J Barker; Sisi Ma; Mark O West
Journal:  Synapse       Date:  2011-11-03       Impact factor: 2.562

2.  Plasma cocaine levels, metabolites, and locomotor activity after subcutaneous cocaine injection are stable across the postpartum period in rats.

Authors:  Michael P Wansaw; Shen-Nan Lin; Joan I Morrell
Journal:  Pharmacol Biochem Behav       Date:  2005-08-22       Impact factor: 3.533

3.  Initial locomotor sensitivity to cocaine varies widely among inbred mouse strains.

Authors:  T Wiltshire; R B Ervin; H Duan; M A Bogue; W C Zamboni; S Cook; W Chung; F Zou; L M Tarantino
Journal:  Genes Brain Behav       Date:  2015-03       Impact factor: 3.449

4.  Evaluation of a pharmacokinetic hypothesis for reduced locomotor stimulation from methamphetamine and cocaine in adolescent versus adult male C57BL/6J mice.

Authors:  Jonathan A Zombeck; Tripta Gupta; Justin S Rhodes
Journal:  Psychopharmacology (Berl)       Date:  2008-09-17       Impact factor: 4.530

5.  Mechanisms of acute cocaine toxicity.

Authors:  Kennon Heard; Robert Palmer; Nancy R Zahniser
Journal:  Open Pharmacol J       Date:  2008

6.  Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine.

Authors:  Max Zhan; Shurong Hou; Chang-Guo Zhan; Fang Zheng
Journal:  Biochem J       Date:  2014-01-01       Impact factor: 3.857

7.  Rapid phasic activity of ventral pallidal neurons during cocaine self-administration.

Authors:  David H Root; Anthony T Fabbricatore; Sisi Ma; David J Barker; Mark O West
Journal:  Synapse       Date:  2010-09       Impact factor: 2.562

8.  Varying the rate of intravenous cocaine infusion influences the temporal dynamics of both drug and dopamine concentrations in the striatum.

Authors:  Ellie-Anna Minogianis; Waqqas M Shams; Omar S Mabrouk; Jenny-Marie T Wong; Wayne G Brake; Robert T Kennedy; Patrick du Souich; Anne-Noël Samaha
Journal:  Eur J Neurosci       Date:  2018-07-24       Impact factor: 3.386

9.  The impact of early environmental rearing condition on the discriminative stimulus effects and Fos expression induced by cocaine in adult male and female rats.

Authors:  Stephen J Kohut; Peter G Roma; Catherine M Davis; Gerald Zernig; Alois Saria; Juan M Dominguez; Kenner C Rice; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2008-10-25       Impact factor: 4.530

10.  Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.

Authors:  Murat Oz; Irina Zakharova; Meral Dinc; Toni Shippenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.